Ibrutinib-associated pityriasis rosea-like rash

Carole Bitar; Azeen Sadeghian; Lacey Sullivan; Andrea Murina

doi:10.1016/j.jdcr.2017.06.035

Ibrutinib-associated pityriasis rosea-like rash

JAAD Case Rep. 2017 Dec 19;4(1):55-57. doi: 10.1016/j.jdcr.2017.06.035. eCollection 2018 Jan.

Authors

Carole Bitar¹, Azeen Sadeghian¹, Lacey Sullivan², Andrea Murina¹

Affiliations

¹ Department of Dermatology, Tulane University, New Orleans, Louisiana.
² Department of Dermatopathology, Tulane University, New Orleans, Louisiana.

No abstract available

Keywords: CLL, chronic lymphocytic leukemia; EGFR, epidermal growth factor receptor; PDGFR, platelet-derived growth factor receptor; PR, pityriasis rosea; drug reaction; ibrutinib; pityriasis rosea.

Publication types

Case Reports

Grants and funding

U54 GM104940/GM/NIGMS NIH HHS/United States